Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

By Nakamura Seigo  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint

By Robert Nicholas  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 9-10

Springer Publishing Company

Access to resources Recommend Favorite

Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials

By Blum Joanne   Kohles Joseph   McKenna Edward   Scotto Nana   Hu Sylvia   Odom Dawn   Kaye James   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 431-439

Springer Publishing Company

Access to resources Recommend Favorite

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

By Artac Mehmet  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 174-180

Springer Publishing Company

Access to resources Recommend Favorite

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

By Campiglio Manuela   Bufalino Rosaria   Sandri Marco   Ferri Elisa   Aiello Rosa   Matteis Andrea   Mottolese Marcella   Placido Sabino   Querzoli Patrizia   Jirillo Antonio   Bottini Alberto   Fantini Manuela   Bonetti Andrea   Pedani Fulvia   Mauri Maria   Molino Annamaria   Ferro Antonella   Pupa Serenella   Sasso Marianna   Ménard Sylvie   Balsari Andrea   Tagliabue Elda  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 147-154

Springer Publishing Company

Access to resources Recommend Favorite